PKC-β1 isoform activation is required for EGF-induced NF-κB inactivation and IκBα stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers

American Journal of Physiology - Cell Physiology

Volumn 286, Issue 3 55-3, 2004, Pages

  Banan, A ^a,b   Zhang, L J ^a   Farhadi, A ^a   Fields, J Z ^a   Shaikh, M ^a   Keshavarzian, A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Caco 2 cells; Cytoskeleton; F actin; Growth factors; Gut barrier; Protection; Protein kinase C isoforms

Indexed keywords

COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; F ACTIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOENZYME; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA1; UNCLASSIFIED DRUG; ACTIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PROTEIN KINASE C; SERINE;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTESTINE CELL; INTESTINE FUNCTION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; CELL NUCLEUS; CYTOSKELETON; CYTOSOL; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; OXIDATIVE STRESS; PHOSPHORYLATION; PHYSIOLOGY;

ACTINS; CACO-2 CELLS; CELL NUCLEUS; CYTOSKELETON; CYTOSOL; ENTEROCYTES; EPIDERMAL GROWTH FACTOR; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE C; SERINE; TRANSFECTION;

EID: 1442349767     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00329.2003     Document Type: Article

References (58)

1. Babich M, Foti LR, and Mathias KL. Protein kinase C modulator effects on parathyroid hormone-induced intracellular calcium and morphologic changes in UMR 106-H5 osteoblastic cells. J Cell Biochem 65: 276-285, 1997.
2. Banan A, Choudhary S, Zhang Y, Fields JZ, and Keshavarzian A. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther 291: 1075-1085, 1999.
3. Banan A, Choudhary S, Zhang Y, Fields JZ, and Keshavarzian A. Oxidant-induced intestinal barrier disruption and its prevention by growth factors in a human colonic cell line: role of the microtubule cytoskeleton. Free Radic Biol Med 28: 727-738, 2000.
4. Banan A, Farhadi A, Fields JZ, Mutlu E, Zhang L, and Keshavarzian A. Evidence that nuclear factor-kappa B activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia. J Pharmacol Exp Tizer 306: 13-28, 2003.
5. Banan A, Fields JZ, Choudhary S, Farhadi A, and Keshavarzian A. Upregulation of NF-κB and I-κBα phosphorylation and consequent cytoskeletal dysfunction in colonic mucosa of patients with inflammatory bowel disease (IBD) (Abstract). Gastroenterology 124, Suppl 1: S1338, 2003.
6. Banan A, Fields JZ, Decker H, Zhang Y, and Keshavarzian A. Nitric oxide and its metabolites mediate ethanol-induced microtubule disruption and intestinal barrier dysfunction. J Pharmacol Exp Ther 294: 997-1008, 2000.
7. Banan A, Fields JZ, Farhadi A, Talmage DA, Zhang L, and Keshavarzian A. Activation of delta-isoform of protein kinase C is required for oxidant-induced disruption of both the microtubule cytoskeleton and permeability barrier of intestinal epithelia. J Pharmacol Exp Ther 303: 17-28, 2002.
8. Banan A, Fields JZ, Farhadi A, Talmage DA, Zhang L, and Keshavarzian A. The β1 isoform of protein kinase C mediates the protective effects of egf on the dynamic assembly of the F-actin cytoskeleton and normalization of calcium in human colonic cells. J Pharmacol Exp Ther 310: 852-866, 2002.
9. Banan A, Fields JZ, Talmage DA, Zhang Y, and Keshavarzian A. PKC-β1 mediates EGF protection of microtubules and barrier of intestinal monolayers against oxidants. Am J Physiol Gastrointest Liver Physiol 281: G833-G847, 2001.
10. 2+ in EGF protection of microtubules and intestinal barrier against oxidants. Am J Physiol Gastrointest Liver Physiol 280: G828-G843, 2001.
11. Banan A, Fields JZ, Zhang Y, and Keshavarzian A. iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers. Am J Physiol Gastrointest Liver Physiol 280: G1234-G1246, 2001.
12. Banan A, Fields JZ, Zhang Y, and Keshavarzian A. Phospholipase C-γ inhibition prevents EGF protection of intestinal cytoskeleton and barrier against oxidants. Am J Physiol Gastrointest Liver Physiol 281: G412-G423, 2001.
13. Banan A, Fields JZ, Zhang LJ, Shaikh M, Farhadi A, and Keshavarzian A. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity. J Pharmacol Exp Ther 307: 53-66, 2003.
14. Banan A, McCormack SA, and Johnson LR. Polyamines are required for microtubule formation during mucosal ulcer healing. Am J Physiol Gastrointest Liver Physiol 274: G879-G885, 1998.
15. Banan A, Smith GS, Rieckenberg CL, Kokoska ER, and Miller TA. Protection against ethanol injury by prostaglandins in a human intestinal cell line: role of microtubules. Am J Physiol Gastrointest Liver Physiol 274: G111-G121, 1998.
16. Banan A, Wang JY, McCormack SA, and Johnson LR. Relationship between polyamines, cytoskeletal distribution, and gastric healing in rats. Am J Physiol Gastrointest Liver Physiol 271: G893-G903, 1996.
17. Banan A, Zhang LJ, Multu E, and Keshavarzian A. Increased oxidation injury in intestinal mucosa of patients with inflammatory bowel disease (Abstract). Gastroenterology 118: 4266, 2000.
18. Banan A, Zhang Y, Losurdo J, and Keshavarzian A. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and transforming growth factor alpha in a human colonic cell line. Gut 46: 830-837, 2000.
19. Baeuerle PA and Henkle T. Function and activation of NF-κB in immune system. Annu Rev Immunol 12: 141-179, 1994.
20. Barnes PJ and Karin M. Nuclear factor-κB, a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
21. Bradford MA. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of dye binding. Anal Biochem 72: 224-254, 1976.
22. Chang Q and Tepperman BL. The role of protein kinase C isozymes in TNF-α-induced cytotoxicity to a rat intestinal epithelial cell line. Am J Physiol Gastrointest Liver Physiol 280: G572-G583, 2001.
23. Chen F, Sun SC, Kuh DC, Gaydos LJ, and Demers LM. Essential role of NF-kappa B activation in silica-induced inflammatory mediator production in macrophages. Biochem Biophys Res Commun 214: 985-992, 1995.
24. Cho Y, Klein MG, and Talmage DA. Distinct functions of protein kinase C-alpha and protein kinase C-beta during retinoic acid-induced differentiation of F9 cells. Cell Growth Differ 9: 147-154, 1998.
25. Gilbert T, Le Bivic A, Quaroni A, and Rodreguez-Boulan E. Microtubule organization and its involvement in the biogenic pathways of plasma membrane proteins in Caco-2 intestinal epithelial cells. J Cell Biol 133: 275-288, 1991.
26. Goodnight J, Mischak H, Kolch W, and Mushinski JF. Immunocytochemical localization of eight PKC isoenzymes over-expressed in NIH 3T3 fibroblasts. J Biol Chem 270: 9991-10001, 1995.
27. Gopalakrishna R and Jaken S. Protein kinase C signaling and oxidative stress. Free Radic Biol Med 28: 1349-1361, 2000.
28. Harter JL. Critical values for Dunnett's new multiple range test. Biometrics 16: 671-685, 1960.
29. Hermiston ML and Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270: 1203-1207, 1995.
30. Hollander D. The intestinal permeability barrier: a hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 27: 721-726, 1992.
31. Hollander D. Crohn's disease - a permeability disorder of the tight junction? Gut 26: 1621-1624, 1998.
32. Housey GM, Johnson MD, Hsiao WLW, O'Brian CA, Murphy JP, Kirschmeier P, and Weinstein IB. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts. Cell 52: 343-354, 1988.
33. Hurani MA, Noach AB, Blom-Roosemalen CM, DeBoer AG, Nagelkerke JF, and Breimer DD. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrosulfate: assessment of effect-reversibility and imaging of transepithelial transport routes by laser confocal microscopy. J Pharmacol Exp Ther 267: 942-950, 1993.
34. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, and Sartor RB. Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity. J Immunol 163: 3474-3483, 1999.
35. Kennedy M, Denenberg AG, Szabo C, and Salzman AL. Poly (ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 114: 510-518, 1998.
36. Keshavarzian A, Kanofsky J, List T, Robinson C, Ibrahim C, and Winship D. Excessive production of reactive oxygen metabolites by inflamed colon: analysis by chemiluminescence probe. Gastroenterology 103: 177-185, 1992.
37. Keshavarzian A, Patel M, Iber F, and Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol induced liver damage. Am J Gastroenterol 94: 200-207, 1999.
38. Keshavarzian A, Zhang Y, Kommandori S, Fields JZ, and Banan A. Increased colonic free radicals and oxidative injury to key cytoskeletal proteins in inflammatory bowel disease. Gut 52: 720-728, 2003.
39. Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, and Ishii H. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 42: 180-187, 1998.
40. Maruvada P and Levine AE. Increased transforming growth factor-alpha levels in human colon carcinoma cell lines over-expressing protein kinase C. Int J Cancer 80: 72-77, 1999.
41. McKenna JP, Williams JM, and Hanson PJ. The alpha isoform of protein kinase C inhibits histamine-stimulated adenylate cyclase activity in a particulate fraction of the human gastric cancer cell line HGT-1. Inflamm Res 44: 66-69, 1995.
42. McKenzie SJ, Baker MS, Buffinton GD, and Doe WF. Evidence for oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest 98: 136-141, 1996.
43. Melloni E, Pontremoli S, Sparatore B, Patrone M, Grossi F, Marks PA, and Rifkind RA. Introduction of the β isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells. Proc Natl Acad Sci USA 87: 4417-4420, 1990.
44. Menon SD, Qin S, Guy RG, and Tan YH. Differential induction of nuclear NF-κB protein phosphatase inhibitors in primary and transformed human cells. J Biol Chem 268: 26805-26812, 1993.
45. Meunier VM, Bourrie Y, Berger Y, and Fabre G. The human intestinal epithelial cell line Caco-2: pharmacological and pharmacokinetics applications. Cell Biol Toxicol 11: 187-194, 1995.
46. Mischak H, Goodnight J, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH, and Mushinski JF. Protein kinase C-α and -β in NIH 3T3 cells induce opposite effects on growth morphology, anchorage dependence, and tumorigenicity. J Biol Chem 268: 6090-6096, 1993.
47. Moon RM, Parikh AA, Pritts TA, Fischer JE, Cottongim S, Szabo C, Salzman AL, and Hasselgren PO. Complement component C3 production in IL-1 beta-stimulated human intestinal epithelial cells is blocked by NF-kappa B inhibitors and by transfection with Ser 32/36 mutant I kappa B alpha. J Surg Res 82: 48-55, 1999.
48. Mullin JM, Kampherstein JA, Laughlin KV, Clarkin CE, Miller RD, Szallasi Z, Kachar B, Soler AP, and Rosson D. Protein kinase C-δ increases tight junction permeability in LLC-PK1 cells. Am J Physiol Cell Physiol 275: C544-C554, 1998.
49. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, and Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2: 998-1004, 1996.
50. Persons DA, Wilkison WO, Bell RM, and Finn O. Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts by protein kinase C. Cell 52: 447-458, 1988.
51. Ponzoni M, Lacarelli E, Corrias MV, and Cornaglia-Ferraris P. Protein kinase C isoenzymes in human neuroblasts: involvement of PKC-α in cell differentiation. FEBS Lett 322: 120-124, 1993.
52. Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M, and Remacle J. Development of a sensitive multi-well colorimetric assay for active NF-κB. Nucleic Acids Res 29: E21, 2001.
53. Rogler G, Brand K, Vogl D, Page S, Hofmeister R, Andus T, Knuechel R, Baeuerle PA, Scholrerich J, and Gross V. Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 357-369, 1998.
54. Sanders SE, Madara JL, McGuirk DK, Gelman DS, and Colgan SP. Assessment of inflammatory events in epithelial permeability: a rapid screening method using fluorescein dextrans. Epithelial Cell Biol 4: 25-34, 1995.
55. Schreiber S, Nikolaus S, and Hampe J. Activation of nuclear factor κB in inflammatory bowel disease. Gut 42: 477-484, 1998.
56. Tang G and Leppla SH. Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect Immun 67: 3055-3060, 1999.
57. Unno N, Menconi MJ, Smith M, and Fink MP. Hyperpermeability of intestinal epithelial monolayers induced by NO: effect of low extracellular pH. Am J Physiol Gastrointest Liver Physiol 272: G923-G934, 1997.
58. Yamada T, Sarto RB, Marshall S, Special RD, and Grisham MB. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology 104: 759-771, 1993.